Copyright
©The Author(s) 2022.
World J Clin Cases. Dec 16, 2022; 10(35): 13064-13073
Published online Dec 16, 2022. doi: 10.12998/wjcc.v10.i35.13064
Published online Dec 16, 2022. doi: 10.12998/wjcc.v10.i35.13064
Code | Antimicrobial | Result | MIC |
AMC | Amoxicillin/Clavulanic | Sensitivity | ≤ 4/2 |
AMK | Amikacin | Sensitivity | ≤ 8 |
AMP | Ampicillin | Resistance | 8 |
ATM | Aztreonam | Sensitivity | ≤ 2 |
CAZ | Ceftazidime | Sensitivity | ≤ 1 |
CDR | Cefdinir | - | - |
CEC | Cefaclor | - | - |
CEP | Cephalothin | - | - |
CFM | Cefixime | - | - |
CFP | Cefoperazone | - | - |
CHL | Chloramphenicol | Sensitivity | ≤ 4 |
CID | Cefonicid | - | - |
CIN | Cinoxacin | - | - |
CIP | Ciprofloxacin | Sensitivity | 0.25 |
CL | Colistin | Resistance | > 2 |
CMZ | Cefmetazole | - | - |
CPR | Cefprozil | - | - |
CPX | Cefpodoxime proxetil | - | - |
CRB | Carbenicillin | - | - |
CRO | Ceftriaxone | - | - |
CSL | Cefoperazone/Sulbactam | - | - |
CTT | Cefotetan | - | - |
CTX | Cefotaxime | Sensitivity | ≤ 1 |
CXM | Cefuroxime | - | - |
CZO | Cefazolin | Resistance | > 16 |
CZX | Ceftizoxime | - | - |
DOX | Doxycycline | - | - |
ETP | Ertapenem | - | - |
FEP | Cefepime | Sensitivity | ≤ 2 |
FLE | Fleroxacin | - | - |
FOS | Fosfomycin | - | - |
FOX | Cefoxitin | - | - |
GAT | Gatifloxacin | - | - |
GEN | Gentamicin | Sensitivity | ≤ 2 |
IPM | Imipenem | Sensitivity | ≤ 1 |
KAN | Kanamycin | - | - |
LOM | Lomefloxaccin | - | - |
LOR | Loracarbef | - | - |
LVX | Levofloxacin | Sensitivity | 0.5 |
MAN | Cefamandole | - | - |
MEC | Mecillinam | - | - |
MEM | Meropenem | Sensitivity | ≤ 1 |
MEZ | Mezlocillin | - | - |
MFX | Moxifloxacin | Mediation | 4 |
MNO | Minocycline | - | - |
MOX | Moxalactam | - | - |
NET | Netilmicin | - | - |
NIT | Nitrofurantoin | - | - |
NOR | Norfloxacin | - | - |
OFX | Ofloxacin | - | - |
PIP | Piperacillin | Sensitivity | ≤ 4 |
SAM | Ampicillin-Sulbactam | Sensitivity | ≤ 4/2 |
SSS | Sulfonamides | - | - |
STR | Streptomycin | - | - |
SXT | Trimethoprim-Sulfamethoxazole | Sensitivity | ≤ 0.5/9.5 |
TCC | Ticarcillin/Clavulanic | - | - |
TCY | Tetracycline | Resistance | ≤ 2 |
TIC | Ticarcillin | - | - |
TMP | Trimethoprim | - | - |
TOB | Tobramycin | - | - |
TZP | Piperacillin-Tazobactam | Sensitivity | ≤ 4/4 |
Code | Antimicrobial | Result | MIC |
AMC | Amoxicillin/Clavulanic | Resistance | > 4/2 |
AMP | Ampicillin | Resistance | > 8 |
AZM | Azithromycin | - | - |
CHL | Chloramphenicol | - | - |
CIP | Ciprofloxacin | Resistance | > 4 |
CLI | Clindamycin | - | - |
CLR | Clarithromycin | - | - |
DAP | Daptomycin | - | - |
DOX | Doxycycline | - | - |
ERY | Erythromycin | Resistance | > 4 |
GEN | Gentamicin | Resistance | > 8 |
LNZ | Linezolid | Sensitivity | 1 |
LVX | Levofloxacin | - | - |
MFX | Moxifloxacin | - | - |
MUH | Mupirocin | Resistance | > 256 |
NIT | Nitrofurantoin | Sensitivity | ≤ 16 |
OFX | Ofloxacin | - | - |
OXA | Oxacillin | Resistance | > 2 |
PEN | Penicillin | Resistance | > 0.25 |
QDA | Quinupristin-Dalfopristin | - | - |
RA | Rifampin | Sensitivity | ≤ 0.5 |
RIF | Rifampin | ||
SXT | Trimethoprim-Sulfamethoxazole | Sensitivity | ≤ 1/19 |
TCY | Tetracycline | Resistance | > 8 |
TEC | Teicoplanin | Sensitivity | 4 |
TLT | Telithromycin | - | - |
TMP | Trimethoprim | Sensitivity | 2 |
VAN | Vancomycin | Sensitivity | 2 |
Type | Genera | Number of sequences | Species | Number of sequences |
G+ | Staphylococcus | 7166 | Staphylococcus haemolyticus | 6493 |
Staphylococcus aureus | 88 | |||
G- | Vibrio | 7026 | Vibrio vulnificus | 6491 |
G+ | Streptococcus | 973 | Streptococcus dysgalactiae | 664 |
G- | Fusobacterium | 43 | Fusobacterium necrophorum | 40 |
G- | Klebsiella | 11 | Klebsiella aerogenes | 10 |
- Citation: Lu HY, Gao YB, Qiu XW, Wang Q, Liu CM, Huang XW, Chen HY, Zeng K, Li CX. Successful surgical treatment of polybacterial gas gangrene confirmed by metagenomic next-generation sequencing detection: A case report. World J Clin Cases 2022; 10(35): 13064-13073
- URL: https://www.wjgnet.com/2307-8960/full/v10/i35/13064.htm
- DOI: https://dx.doi.org/10.12998/wjcc.v10.i35.13064